News

With this advancement, Amorfix will be committing additional resources to develop an ultra-sensitive blood test for Alzheimer's disease, based upon Amorfix's patent-pending EP technology. Alzheimer's disease is associated

This could be vital for the treatment of ACS because currently approved drugs do not target the proximal stages of the coagulation process. The reduction of ischemia occurred

Abbott’s goal for the trial was to establish Xience as an equal competitor with the Taxus stent. Discovering the superiority of Xience will enhance the reputation of Abbot

This is the first time that the government of India has approved a product developed from natural sources for use as a pharmaceutical grade drug. Ocufors is used

The first study 012 reported a change in the average weekly frequency of spontaneous bowel movement. Good results were also noted in the investigation of the effect of

The data was presented at the annual European Federation of Neurological Societies Congress. The 24-week study involved patients with Parkinson’s disease not adequately controlled with levodopa (L-dopa). The

This follows a similar case reported earlier from the same trial. The latest patient had four separate tumors at different sites, with a total diameter before treatment of

“The agreement between Mayo Validation Support Services and our company signals an essential step forward in Biomoda’s commitment to developing and commercializing early non invasive diagnostic tests for

The total amount of spending DHL could be handling is understood to be GBP3.7 billion pounds a year, and both parties said the 10-year contract could save the